Skip to main content
Sign In
 

Neda Rasouli, MD

Professor of Medicine


Dr. Rasouli received her MD degree from Tehran University of Medical Sciences, Iran. Her internal medicine residency training was at Michigan State University, Lansing, MI and she completed her endocrinology fellowship at the University of Arkansas for Medical Sciences, Little Rock, AR, in 2002. Dr Rasouli joined the faculty of the University of Colorado, Denver in 2009. Dr. Rasouli is a physician and a researcher at the University of Colorado and Eastern Colorado Veterans Health Care System. Dr Rasouli has special interest in the management and treatment of patients with diabetes, dyslipidemia and other metabolic disorders associated with obesity. Her research interests include studying the pathophysiology of insulin resistance and optimal management of diabetes. She has been the investigator for several large multi-center clinical trials investigating novel treatment for diabetes, obesity and lipid disorders. Dr Rasouli is the director of Diabetes and Endocrinology Clinical Trial program​.
 
  • Diabetes
  • Metabolic disorders associated with obesity
  • Insulin Resistance
  • Lipotoxicity and adipose tissue inflammation associated with obesity and insulin resistance
  • PPAR ligands on adipose tissue inflammation
  • Diabetes
  • Metabolic disorders
  • Obesity​
For more information on clinical trials, please visit Diabetes and Endocrinology Clinical Trial program.​​

Medical Schools

MD, Tehran University of Medical Sciences, Iran (1995)

Residency Program
Michigan State University Program, Internal Medicine (2000)

Fellowships
University of Arkansas for Medical Sciences Program, Internal Medicine - Endocrinology, Diabetes, and Metabolism (2002)

Selected Publications

  1. Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.
    Rasouli N, Kern PA, Elbein SC, Sharma NK, Das SK. 
    Pharmacogenet Genomics. 2012 Mar 19. [Epub ahead of print]
     
  2. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy.
    Hsia E, Seggelke SA, Gibbs J, Rasouli N, Draznin B. 
    Nutr Clin Pract. 2011 Dec;26(6):714-7.
     
  3. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. 
    Spencer M, Unal R, Zhu B, Rasouli N, McGehee RE Jr, Peterson CA, Kern PA. 
    J Clin Endocrinol Metab. 2011 Dec;96(12):E1990-8. Epub 2011 Oct 12.
     
  4. Global gene expression profiles of subcutaneous adipose and muscle from glucose-tolerant, insulin-sensitive, and insulin-resistant individuals matched for BMI. 
    Elbein SC, Kern PA, Rasouli N, Yao-Borengasser A, Sharma NK, Das SK. 
    Diabetes. 2011 Mar;60(3):1019-29. Epub 2011 Jan 24.
     
  5. Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone. 
    Yao-Borengasser A, Varma V, Coker RH, Ranganathan G, Phanavanh B, Rasouli N, Kern PA. 
    Metabolism. 2011 Jul;60(7):1012-20. Epub 2010 Dec 3.
     
  6. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. 
    Spencer M, Yao-Borengasser A, Unal R, Rasouli N, Gurley CM, Zhu B, Peterson CA, Kern PA. 
    Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E1016-27. Epub 2010 Sep 14.
     
  7. Insulin resistance in African-American and Caucasian women: differences in lipotoxicity, adipokines, and gene expression in adipose tissue and muscle. 
    Smith LM, Yao-Borengasser A, Starks T, Tripputi M, Kern PA, Rasouli N
    J Clin Endocrinol Metab. 2010 Sep;95(9):4441-8. Epub 2010 Jun 30.
     
  8. Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. 
    Unal R, Yao-Borengasser A, Varma V, Rasouli N, Labbate C, Kern PA, Ranganathan G. 
    J Clin Endocrinol Metab. 2010 Jun;95(6):2993-3001. Epub 2010 Apr 14.
     
  9. Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. 
    Rasouli N, Yao-Borengasser A, Varma V, Spencer HJ, McGehee RE Jr, Peterson CA, Mehta JL, Kern PA. 
    Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1328-35. Epub 2009 Aug 10.
     
  10. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. 
    Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, Starks T, Gurley C, Simpson P, McGehee RE Jr, Kern PA, Peterson CA. 
    Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1300-10. Epub 2009 Mar 31.​